health-technologyNVIDIA BioNeMo Platform Secures Partnerships with Eli Lilly, Thermo Fisher for AI Drug DiscoverySalvado•Apr 21, 2026
biotechnologyAI-Designed Cancer Drug BD200 Defeats Resistant Tumors, Outperforms Marketed AntibodiesSalvado•Apr 19, 2026
Health & ScienceAI-Designed Antibody BD200 Outperforms Standard Treatments in Drug-Resistant Cancers, Marking First Clinical Trial for Machine Learning PlatformSalvado•Apr 18, 2026
Healthcare TechnologyNVIDIA's BioNeMo Platform Powers $1.3 Trillion Pharma Industry's AI Pivot Across Three ContinentsSalvado•Apr 18, 2026
biotechnologyFDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in DealsSalvado•Apr 16, 2026
HealthcareNVIDIA Captures Global Drug Discovery AI Market Through Eli Lilly, Thermo Fisher DealsSalvado•Apr 14, 2026
HealthcareNVIDIA's BioNeMo Platform Deployed by Eli Lilly, Thermo Fisher, Six Biotech Firms for AI Drug DiscoverySalvado•Apr 11, 2026
AI & TechnologyNVIDIA Locks Down Global Pharma AI Infrastructure Through Eli Lilly, Thermo Fisher Platform DealsSalvado•Apr 11, 2026
health-techNVIDIA's Drug Discovery AI Platform Secures Eli Lilly, Thermo Fisher Partnerships Across Three ContinentsSalvado•Mar 29, 2026
BiotechBiotech Firms Secure Capital as Gene Therapy Trials Target 5 Million Global Patients with Dry AMDSalvado•Mar 26, 2026
Healthcare InnovationAI-Designed Drug Candidates Show Clinical Progress Across US and Canadian TrialsSalvado•Mar 24, 2026
Healthcare TechnologyNVIDIA BioNeMo Platform Adopted by Eli Lilly and Thermo Fisher for AI Drug DiscoverySalvado•Mar 23, 2026
pharmaceuticalsAustralian biotech Vectus faces delisting as XORTX asset sale threatens capital runwayViaNews Editorial Team•Feb 23, 2026
biotechnologyCannabis Biotech Bets Everything on Single Intoxication Drug as Global THC Products Hit 90% PotencyViaNews Editorial Team•Feb 23, 2026
Science & TechnologyNVIDIA's BioNeMo Aims to Become the Global Infrastructure Layer for Drug DiscoveryViaNews Editorial Team•Feb 18, 2026
Healthcare & PharmaceuticalsGene Therapy, mRNA and CRISPR: The Global Biotech Boom Reshaping How the World Finances MedicineViaNews Editorial Team•Feb 18, 2026
AnalysisFour Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near MarketViaNews Editorial Team•Feb 15, 2026
AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsViaNews Editorial Team•Feb 15, 2026
AnalysisNVIDIA Targets Drug Discovery Market With AI Infrastructure PushViaNews Editorial Team•Feb 15, 2026
AnalysisBiotech Revolution is Underway: An Overview of a Fast-Growing IndustryRuchi Gupta•Nov 7, 2019
